Andrew R. Haas MD, PhD

Dr. Andrew Haas is currently Director of Clinical Operations for the Section of Interventional Pulmonology and Thoracic Oncology at the University of Pennsylvania Medical Center. Dr. Haas has advanced training in the following techniques: flexible and rigid bronchoscopy; balloon bronchoplasty, endobronchial stent placement (metal and silicone), endobronchial brachytherapy, photodynamic therapy, auto-fluorescence bronchoscopy (LIFE), transbronchial needle aspiration/biopsy, bronchoscopic electrosurgery (including argon plasma coagulation), endobronchial ultrasound (radial and convex probe), percutaneous tracheotomy, and pleuroscopy.

His clinical interests are related to the treatment of thoracic malignancies, specifically with regard to the application of novel technologies in Interventional Pulmonology to design and to improve the diagnosis and treatment of thoracic malignancies. His research interests are in the translation of laboratory discoveries from the bench to the bedside: conducting human clinical trials of gene therapy and vaccine therapy for lung cancer, mesothelioma, and other pleural malignancies.